| 1 | 2245-25-2 | Oxirane, 2-ethyl-2-phenyl- | C10H12O | 148.2 | | |
| 2 | 2245-29-6 | Neopentyloxirane | | | | |
| 3 | 2245-30-9 | 3,3-Dimethyl-1,2-Epoxybutane | C6H12O | 100.16 | | |
| 4 | 2245-32-1 | 1,2-PROPYLENE-3,3,3-D3 OXIDE | C3H6O | 58.08 | | |
| 5 | 2245-38-7 | 1,6,7-Trimethylnaphthalene | C13H14 | 170.25 | | |
| 6 | 2245-43-4 | 4-AdaMantyl-1-broMobenzene | C16H19Br | 291.23 | 102-103℃ (methanol ) | |
| 7 | 2245-52-5 | (4-ethenylphenyl)-N,N-dimethylmethanaminium | C11H15N | 161.24 | | |
| 8 | 2245-53-6 | 2,2'-[1,4-phenylenebis(oxy)]bisacetic acid | C10H10O6 | 226.18 | 248-251 °C | Slightly soluble in water. |
| 9 | 2245-75-2 | 1H-Indole-2-carboxylic acid, 3-(2-aminoethyl)-5,7-dimethyl- | C13H16N2O2 | 232.27834 | | |
| 10 | 2245-77-4 | FEMA 3506 | C34H42N2O8 | 606.71 | | |
| 11 | 2245-90-1 | FQCHMMSXFIZMRW-UHFFFAOYSA-N | C11H16ClNO3 | 245.70264 | | |
| 12 | 2245-94-5 | anhalidine | C12H17NO3 | 223.27 | | |
| 13 | 22450-90-4 | amminephenylmercury(1+) acetate | C8H11HgNO2-2 | 353.76844 | | |
| 14 | 22450-96-0 | Hydrogen bis [2-(hydroxyl-kappa O) benzoate (2-)-kappa O]-(T-4)-borate (1-) coMpound with N,N-dibutyl-1-butanaMine (1:1:1) (SABoTBA) | C26H36BNO6 | 469.39 | | |
| 15 | 22450-98-2 | hydrogen bis[benzene-1,2-diolato(2-)-O,O']borate(1-) | C12H9BO4 | 228.01 | | |
| 16 | 2245019-44-5 | 3-Iodo-4-(methoxymethoxy)-1,1'-biphenyl | C14H13IO2 | 340.16 | | |
| 17 | 2245020-50-0 | Carbamic acid, N-[(1S)-4-[[(3-chloro-4-fluorophenyl)amino]carbonyl]-7-fluoro-2,3-dihydro-1H-inden-1-yl]-, (1-methyl-1H-1,2,4-triazol-3-yl)methyl ester | C21H18ClF2N5O3 | 461.85 | | |
| 18 | 2245023-88-3 | 2-chloro-7-(4-methoxybenzyl)-7H-pyrrolo[2,3-d]pyrimidine | | | | |
| 19 | 2245024-36-4 | 1,2-Benzisothiazole, 4-bromo-2,3-dihydro-, 1,1-dioxide | C7H6BrNO2S | 248.1 | | |
| 20 | 2245035-65-6 | 1-chloro-6-fluorodibenzofuran | C12H6ClFO | 220.63 | | |
| 21 | 2245035-70-3 | Dibenzofuran, 1-chloro-7-fluoro- | C12H6ClFO | 220.63 | | |
| 22 | 2245053-33-0 | 2-(4-((2-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C19H22BFO3 | 328.1855832 | | |
| 23 | 2245053-57-8 | 1-Propanone, 1-[5-[(2,3-dihydro-1,4-dioxino[2,3-b]pyridin-7-yl)sulfonyl]-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl]-3-hydroxy-2-phenyl-, (2S)- | C22H23N3O6S | 457.5 | | |
| 24 | 2245054-22-0 | Pyrrolo[3,4-c]pyrrole-2(1H)-carboxylic acid, 5-[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]-3,4,5,6-tetrahydro-, 1,1-dimethylethyl ester | C19H24N2O6S | 408.47 | | |
| 25 | 2245054-23-1 | Pyrrolo[3,4-c]pyrrole, 2-[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]-1,2,3,4,5,6-hexahydro- | C14H16N2O4S | 308.35 | | |
| 26 | 2245057-57-0 | G-1749 | C28H30N6O3 | 498.58 | | |
| 27 | 2245062-49-9 | 1-Naphthalenamine, 6-methyl-5-[[3-[2-(methylthio)-4-pyrimidinyl]-2-pyridinyl]oxy]- | C21H18N4OS | 374.46 | | |
| 28 | 2245065-75-0 | benzyl (3R,5S)-3-amino-5-methyl-piperidine-1-carboxylate hydrochloride | C14H20N2O2.ClH | 284.78 | | |
| 29 | 2245066-84-4 | (4-Chloro-1-methyl-1H-pyrazol-3-yl)methanesulfonyl chloride | C5H6Cl2N2O2S | 229.08 | | |
| 30 | 2245069-23-0 | Levetiracetam M | | | | |
| 31 | 2245069-23-1 | Levetiracetam Impurity 77 (N-Nitroso Levetiracetam EP Impurity G) | | | | |
| 32 | 2245072-20-0 | LIT-001 free base | C28H33N7O2S | 531.67 | | |
| 33 | 2245072-21-1 | (S)-2-(Dimethylcarbamothioyl)-N-(2-methyl-4-(1-methyl-1,4,5,10-tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine-5-carbonyl)benzyl)pyrrolidine-1-carboxamide, Trifluoroacetate | C30H34F3N7O4S | 645.7 | | |
| 34 | 2245073-05-4 | 2245073-05-4 | C112H184N40O25S3 | 2587.14 | | |
| 35 | 2245074-20-6 | Ethanol, 2-[2-methoxy-4-[[(1-phenyl-1H-benzimidazol-5-yl)amino]methyl]phenoxy]- | C23H23N3O3 | 389.45 | | |
| 36 | 2245080-12-8 | Benzo[1,2-b:4,3-b′]bisbenzofuran, 1-chloro- | C18H9ClO2 | | | |
| 37 | 2245081-78-9 | (S)-1'-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-1,3-dihydrospiro[indene-2,4'-piperidin]-1-amine | | | | |
| 38 | 2245082-05-5 | Spiro[6H-cyclopenta[b]pyridine-6,4'-piperidin]-5-amine, 1'-[5-[(2-amino-3-chloro-4-pyridinyl)thio]-2-pyrazinyl]-5,7-dihydro-, (5S)- | C21H22ClN7S | 439.96 | | |
| 39 | 2245084-40-4 | tert-Butyl 5-oxo-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4'-piperidine]-1'-carboxylate | C17H22N2O3 | 302.37 | | |
| 40 | 2245084-41-5 | tert-Butyl 6-bromo-1-oxo-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate | C18H22BrNO3 | 380.28 | | |
| 41 | 2245084-43-7 | tert-butyl 4-bromo-1-oxo-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate | | | | |
| 42 | 2245084-46-0 | Spiro[2H-indene-2,4'-piperidine]-1'-carboxylic acid, 5-bromo-6-fluoro-1,3-dihydro-3-oxo-, 1,1-dimethylethyl ester | C18H21BrFNO3 | 398.27 | | |
| 43 | 2245084-47-1 | tert-Butyl 5,6,7-Trifluoro-1-oxo-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate | C18H20F3NO3 | 355.35 | | |
| 44 | 2245084-51-7 | tert-butyl 5,6-difluoro-1-oxo-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate | C18H21F2NO3 | 337.36 | | |
| 45 | 2245084-53-9 | 1’-Boc-6-chloro-5-methoxy-1-oxo-1,3-dihydrospiro[indene-2,4’-piperidine | C19H24ClNO4 | 365.85 | | |
| 46 | 2245084-89-1 | Spiro[6H-cyclopenta[b]pyridine-6,4'-piperidine]-1'-carboxylic acid, 5,7-dihydro-7-oxo-, 1,1-dimethylethyl ester | C17H22N2O3 | 302.37 | | |
| 47 | 2245084-91-5 | Spiro[5H-cyclopentathiazole-5,4'-piperidine]-1'-carboxylic acid, 2-chloro-4,6-dihydro-4-oxo-, 1,1-dimethylethyl ester | C15H19ClN2O3S | 342.84 | | |
| 48 | 2245085-40-7 | tert-Butyl (S)-1-(((R)-tert-butylsulfinyl)amino)-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate | C22H34N2O3S | 406.58 | | |
| 49 | 2245085-41-8 | 2-Propanesulfinamide, N-[(1S)-1,3-dihydrospiro[2H-indene-2,4'-piperidin]-1-yl]-2-methyl-, [S(R)]- | C17H26N2OS | 306.47 | | |
| 50 | 2245085-49-6 | tert-butyl 6-oxo-5,6-dihydrospiro[cyclopenta[b]pyridine-7,4'-piperidine]-1'-carboxylate | C17H22N2O3 | 302.37 | | |
| 51 | 2245085-51-0 | tert-Butyl (R)-6-(((S)-tert-butylsulfinyl)amino)-5,6-dihydrospiro[cyclopenta[b]pyridine-7,4'-piperidine]-1'-carboxylate | | | | |
| 52 | 2245085-54-3 | (1S)-1'-Boc-1-(R)-tert-butylsulfinylamino-6-methoxy-spiroindane-2,4'-piperidine | C23H36N2O4S | 436.61 | | |
| 53 | 2245093-17-6 | 1H-Indazole, 6-bromo-1-methyl-3-[[4-(trifluoromethoxy)phenoxy]methyl]- | C16H12BrF3N2O2 | 401.18 | | |
| 54 | 2245093-18-7 | 1H-Indazole, 6-ethenyl-1-methyl-3-[[4-(trifluoromethoxy)phenoxy]methyl]- | C18H15F3N2O2 | 348.32 | | |
| 55 | 2245093-35-8 | 1H-Indazole, 6-bromo-1-methyl-3-[1-[4-(trifluoromethoxy)phenoxy]ethyl]- | C17H14BrF3N2O2 | 415.2 | | |
| 56 | 2245093-48-3 | 1H-Indazole-6-carboxaldehyde, 3-iodo-1-methyl- | C9H7IN2O | 286.07 | | |
| 57 | 2245098-00-2 | Biphenyl-4-yl-(3'-carbazol-9-yl-biphenyl-4-yl)-(4-dibenzofuran-4-yl-phenyl)-amine | C54H36N2O | 728.88 | | |
| 58 | 22451-06-5 | Sodium Tellurite Pentahydrate | Na2TeO3·5H2O | 221.58(asAnhydrous) | 300°C(dec.)(lit.) | |
| 59 | 22451-37-2 | Ethanol, 2-(diethylamino)-, conjugate acid (1:1) | C6H16NO+ | 118.2 | | |
| 60 | 22451-48-5 | Cyclohexanemethanol, 4-(1-methylethenyl)-, trans- | C10H18O | 154.25 | | |
| 61 | 22451-50-9 | (+/-)-CIS- AND TRANS-1,2-DIHYDROPERILLALDEHYDE | C10H16O | 152.23344 | | |
| 62 | 22451-63-4 | (E)-7-methyl-3-methyleneocta-4,6-dien-2-ol | C10H16O | 152.23 | | |
| 63 | 22451-73-6 | 5-Azulenemethanol,1,2,3,3a,4,5,6,7-octahydro-.alpha.,.alpha.,3,8-tetramethyl-,[3S- | C15H26O | 222.37 | 69-70 °C | |
| 64 | 2245102-84-3 | (4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methanamine hydrochloride | C7H17BClNO2 | 193.48 | | |
| 65 | 2245103-02-8 | methyl (1R,3R,4R)-4-bromo-3-hydroxy-cyclohexanecarboxylate | | | | |
| 66 | 2245103-03-9 | Cyclohexanecarboxylic acid, 4-bromo-3-fluoro-, methyl ester, (1R,3S,4R)- | C8H12BrFO2 | 239.08 | | |
| 67 | 2245104-25-8 | (6,6)Carbon Nanobelt Bis(tetrahydrofuran) Adduct | C56H40O2 | 744.9299999999999 | | |
| 68 | 2245109-85-5 | methyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[2.2.2]octane-1-carboxylate | C16H27BO4 | 294.19418 | | |
| 69 | 2245111-15-1 | 3-Pyridazinecarboxylic acid, 4,6-dichloro-, lithium salt, hydrate (1:1:1) | C5H5Cl2LiN2O3 | 218.95 | | |
| 70 | 2245111-18-4 | 3-Pyridazinecarboxylic acid, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]- | C19H19N7O4 | 409.4 | | |
| 71 | 2245111-19-5 | 3-Pyridazinecarboxylic acid, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-, zinc salt (2:1) | C19H19N7O4Zn | 474.79 | | |
| 72 | 2245111-20-8 | 3-(5-chloro-2-methoxyphenyl)-1-methyl-1H-1,2,4-triazole sulfate | C10H10ClN3O | 223.66 | | |
| 73 | 2245111-21-9 | 1H-1,2,4-Triazole, 3-(5-chloro-2-methoxy-3-nitrophenyl)-1-methyl- | C10H9ClN4O3 | 268.66 | | |
| 74 | 2245128-70-3 | Phenol, 3-(4,6-diphenyl-1,3,5-triazin-2-yl)- | C21H15N3O | 325.36 | | |
| 75 | 2245131-93-3 | Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone, 4,9-dibromo-2,7-di-3,6,9,12-tetraoxatridec-1-yl- | C32H40Br2N2O12 | 804.47 | | |
| 76 | 2245137-17-9 | 1,3-Dioxoisoindolin-2-yl 2-ethylbutanoate | C14H15NO4 | 261.27 | | |
| 77 | 2245150-18-7 | Methyltetrazine-PEG4-amine HCl salt | C17H26ClN5O4 | 399.88 | | |
| 78 | 2245159-01-5 | Nicotinamide Impurity 149 | | | | |
| 79 | 2245159-93-5 | tert-Butyl (1-formylnaphthalen-2-yl) carbamate | C16H17NO3 | 271.32 | | |
| 80 | 2245163-77-1 | 6-bromo-3-cyclohexylquinazolin-4(3H)-one | C14H15BrN2O | 307.19 | | |
| 81 | 2245167-79-5 | Ticagrelor Impurity 26 | C21H24F2N6O3S | 478.52 | | |
| 82 | 2245167-80-8 | Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(5-chloro-2-ethoxyphenyl)-5-methyl-7-propyl- | C17H19ClN4O2 | 346.81 | | |
| 83 | 2245171-87-1 | Ethane, 1-[difluoro(trifluoromethoxy)methoxy]-1,1,2,2-tetrafluoro-2-methoxy- | C5H3F9O3 | 282.06 | | |
| 84 | 2245186-89-2 | 1-(Azetidin-3-yl)-1H-imidazole. Hydrochloride | C6H10ClN3 | 159.62 | | |
| 85 | 2245190-85-4 | 1H-Pyrazol-5-amine, 3-(3-azetidinyl)- | C6H10N4 | 138.17 | | |
| 86 | 2245195-67-7 | HeE1-2Tyr | C33H30N2O6S | 582.67 | | |
| 87 | 2245197-07-1 | Dapoxetine-004 | C30H31NO | 421.58 | | |
| 88 | 2245197-11-7 | Benzenemethanol, α-[2-[[4-(3-phenyl-2-propen-1-yl)-1-naphthalenyl]oxy]ethyl]- | C28H26O2 | 394.51 | | |
| 89 | 22452-23-9 | 1,3-Dithiane, 4,6-dimethyl-, (4R,6S)-rel- | C6H12S2 | 148.29 | | |
| 90 | 22452-25-1 | 1,3-Oxathiane, 4,6-dimethyl-, (4R,6S)-rel- | C6H12OS | 132.22 | | |
| 91 | 22452-26-2 | NISTC22452262 | C6H12OS | 132.22388 | | |
| 92 | 22452-49-9 | Chromium(1+), tetraamminedichloro-, (OC-6-12)- | Cl2CrH8N4+ | 186.99 | | |
| 93 | 22452-55-7 | Naphtho[2,3-c]furan-6-carbonyl chloride, 1,3-dihydro-1,3-dioxo- | C13H5ClO4 | 260.63 | | |
| 94 | 22452-69-3 | Benzoic acid, 3,3'-isopropylidenedi- (6CI,8CI) | C17H16O4 | 284.31 | | |
| 95 | 22452-74-0 | 3-(3-carboxyphenyl)sulfonylbenzoic acid | C14H10O6S | 306.29 | | |
| 96 | 22452-82-0 | 2α,3β,23-Trihydroxyoleana-12-ene-28-oic acid methyl ester | C31H50O5 | 502.74 | | |
| 97 | 2245205-37-0 | Idactamab | | | | |
| 98 | 2245209-60-1 | Benzeneacetic acid, 3-(2-chloroethyl)-α,α-dimethyl-, methyl ester | C13H17ClO2 | 240.73 | | |
| 99 | 2245230-79-7 | HKPerox-2 | | | | |
| 100 | 2245231-10-9 | 1H-Pyrrolo[2,3-b]pyridine-5-acetic acid, 4-(4-chlorophenyl)-α-(1,1-dimethylethoxy)-2,3,6-trimethyl-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-, (αS)- | C27H31ClN4O3 | 495.02 | | |
| 101 | 2245231-51-8 | BRD5018 | C33H38N4O4 | 554.68 | | |
| 102 | 2245237-53-8 | 2,6-Diazaspiro[3.3]heptane, 2-[6-chloro-1-[(4-fluoro-3,5-dimethylphenyl)methyl]-4-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]- | C26H32ClFN6 | 483.02 | | |
| 103 | 2245237-54-9 | SOS1 activator 2 | | | | |
| 104 | 2245237-61-8 | 2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[4-bromo-6-chloro-1-[(4-fluoro-3,5-dimethylphenyl)methyl]-1H-benzimidazol-2-yl]-, 1,1-dimethylethyl ester | C26H29BrClFN4O2 | 563.89 | | |
| 105 | 2245238-80-4 | 4,6-Dichloro-3-pyridazinecarboxylic acid, lithium salt (1:1) | C5H3Cl2LiN2O2 | 200.93 | | |
| 106 | 2245244-85-1 | 2H-1,4-Benzoxazin-3(4H)-one, 6-(1,4-dihydro-1-methyl-4-oxo-5H-pyrazolo[3,4-d]pyrimidin-5-yl)-7-fluoro-4-(2-propyn-1-yl)- | C17H12FN5O3 | 353.31 | | |
| 107 | 2245255-65-4 | GSK2807 | C19H32N8O5 | 452.52 | | |
| 108 | 2245255-66-5 | GSK2807 Trifluoroacetate | C21H33F3N8O7 | 566.54 | | |
| 109 | 2245256-60-2 | 2-(4-(3,6-Di-tert-butyl-9H-carbazol-9-yl)phenyl)acetonitrile | C28H30N2 | 394.55 | | |
| 110 | 2245256-97-5 | 1-(4-(chloromethyl)benzyl)-5-methylindoline-2, 3-dione | | | | |
| 111 | 2245262-31-9 | 2-Piperidinone, 6-[(acetyloxy)methyl]-5-methyl-1-(2-propen-1-yl)-, (5S,6S)- | C12H19NO3 | 225.28 | | |
| 112 | 2245262-36-4 | 2-Piperidinone, 6-(iodomethyl)-5-methyl-1-(2-propen-1-yl)-, (5R,6R)- | C10H16INO | 293.14 | | |
| 113 | 2245262-37-5 | 2-Piperidinone, 5-methyl-1,6-di-2-propen-1-yl-, (5R,6S)- | C12H19NO | 193.29 | | |
| 114 | 2245262-44-4 | 1,4-Benzenedicarboxaldehyde, 2,5-bis[2-(2-azidoethoxy)ethoxy]- | C16H20N6O6 | 392.37 | | |
| 115 | 2245262-45-5 | (5S,6S)-6-(Hydroxymethyl)-5-methyl-1-(2-propen-1-yl)-2-piperidinone | C10H17NO2 | 183.25 | | |
| 116 | 2245262-53-5 | 2-Piperidinone, 6-(iodomethyl)-5-methyl-1-(2-propen-1-yl)-, (5S,6S)- | C10H16INO | 293.14 | | |
| 117 | 2245262-54-6 | 2-Piperidinone, 5-methyl-1,6-di-2-propen-1-yl-, (5S,6R)- | C12H19NO | 193.29 | | |
| 118 | 2245272-16-4 | Antitumor agent-104 | C31H33FN6O3 | 556.63 | | |
| 119 | 2245272-21-1 | 11,12-EET-CoA | | | | |
| 120 | 2245272-22-2 | 14,15-EET-CoA | | | | |
| 121 | 2245275-82-3 | Butyphthalide impurity 36 | C15H18O5 | 278.3 | | |
| 122 | 2245279-95-0 | UC 514321 | | | | |
| 123 | 22453-06-1 | VIOLERYTHRIN | C38H44O4 | 564.75356 | | |
| 124 | 22453-07-2 | 3,3'-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonene-1,18-diyl]bis[(S)-5-hydroxy-2,4,4-trimethyl-2-cyclopenten-1-one] | C38H48O4 | 568.79 | | |
| 125 | 22453-08-3 | 2,2'-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonene-1,18-diyl]bis(1,1,3-trimethyl-1H-cyclopenta[b]quinoxaline) | C50H52N4 | 708.97468 | | |
| 126 | 22453-82-3 | MFCD01134714 | C18H12N2OS | 304.37 | | |
| 127 | 2245315-85-7 | 2-Propenamide, N-[3-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]phenyl]-3-phenyl- | C31H33N3O2S | 511.68 | | |
| 128 | 2245319-25-7 | PIKfyve-IN-2 | C22H22N8O | 414.46 | | |
| 129 | 2245322-56-7 | 3,4-dihydro-4,4-dimethyl-2H-1-Benzopyran-8-carboxylic acid | C12H14O3 | 206.23776 | | |
| 130 | 2245327-05-1 | 1-Azido-4-(phenylmethoxy)-2-butanone | C11H13N3O2 | 219.24 | | |
| 131 | 2245335-70-8 | 1,3,2-Benzoxathiaphosphole, hexahydro-3a-methyl-6-(1-methylethenyl)-2-[(2,3,4,5,6-pentafluorophenyl)thio]-, 2-sulfide, (2S,3aS,6R,7aS)- | C16H16F5OPS3 | 446.46 | | |
| 132 | 2245335-71-9 | 1,3,2-Benzoxathiaphosphole, hexahydro-3a-methyl-6-(1-methylethenyl)-2-[(2,3,4,5,6-pentafluorophenyl)thio]-, 2-sulfide, (2R,3aR,6S,7aR)- | C16H16F5OPS3 | 446.46 | 102-107 °C | |
| 133 | 2245340-46-7 | Pyridine, 2-(4-dibenzofuranyl)-4-(2,2-dimethylpropyl)- | C22H21NO | 315.41 | | |
| 134 | 2245352-66-1 | 1-(2-(trifluoromethyl)-4-(methylsulfonyl)benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridine | C17H15F3N2O2S | 368.37 | | |
| 135 | 2245358-13-6 | Carbamic acid, N-?(3-?chloro-?6-?fluoro-?9H-?pyrido[2,?3-?b]?indol-?8-?yl)?-?N-?methyl-?, 1,?1-?dimethylethyl ester | C17H17ClFN3O2 | 349.79 | | |
| 136 | 2245358-17-0 | tert-butyl (3,4-dichloro-6-fluoro-9H-pyrido[2,3-b]indol-8-yl)(methyl)carbamate | C17H16Cl2FN3O2 | 384.2322432 | | |
| 137 | 2245358-54-5 | 2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylmethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)- | C13H23N3O5S3 | 397.53 | | |
| 138 | 2245358-55-6 | tert-Butyl (3,4-dichloro-5-cyano-6-fluoro-9H-pyrido[2,3-b]indol-8-yl)(methyl)carbamate | C18H15Cl2FN4O2 | 409.24 | | |
| 139 | 2245359-79-7 | Pyrrolo[3,4-b]-1,4-oxazine, octahydro-4-methyl-, (4aR,7aS)-rel- | C7H14N2O | 142.2 | | |
| 140 | 2245360-34-1 | Pyrrolo[3,4-b]-1,4-oxazine, octahydro-4-methyl-, hydrochloride (1:2), (4aR,7aS)-rel- | C7H15ClN2O | 178.66 | | |
| 141 | 2245362-61-0 | 1H-Dibenzo[de,g]quinoline, 2,3,3a,4,5,6,6a,7,11b,11c-decahydro-6,10-dimethyl- | C18H25N | 255.4 | | |
| 142 | 22454-49-5 | N'-[1-(4-methylphenyl)ethylidene]benzohydrazide | C16H16N2O | 252.31 | | |
| 143 | 22454-53-1 | TIMTEC-BB SBB006097 | C14H11ClN2O | 258.7 | | |
| 144 | 22454-54-2 | Benzoic acid,2-[(2,6-dichlorophenyl)methylene]hydrazide | C14H10Cl2N2O | 293.148 | | |
| 145 | 22454-55-3 | Benzoic acid,2-[1-(2-methoxyphenyl)ethylidene]hydrazide | C16H16N2O2 | 268.31044 | | |
| 146 | 22454-56-4 | Benzoic acid,2-[1-(3-methoxyphenyl)ethylidene]hydrazide | C16H16N2O2 | 268.31044 | | |
| 147 | 22454-57-5 | Benzoic acid,2-[1-(4-methoxyphenyl)ethylidene]hydrazide | C16H16N2O2 | 268.31044 | | |
| 148 | 22454-79-1 | 4-Pyrimidinemethanamine, 2-methyl- (9CI) | C6H9N3 | 123.16 | | |
| 149 | 22454-80-4 | 3-Benzylideneamino-4-phenylthiazoline-2-thione | C16H12N2S2 | 296.41 | | |
| 150 | 22454-86-0 | calcium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate | C5H6CaN2O4 | 198.19 | 197-199°C | |
| 151 | 22454-89-3 | Phosphoric acid,3,5-dimethyl-4-(methylthio)phenyl diethyl ester | C13H21O4PS | 304.342201 | | |
| 152 | 22454-95-1 | 1,5-Dioxaspiro[5.5]undecane,3,3-diethyl-9-methyl- | C14H26O2 | 226.35504 | | |
| 153 | 22454-96-2 | 1,3-Dioxane,4,5,5-trimethyl-2-(6-methyl-3-cyclohexen-1-yl)- | C14H24O2 | 224.33916 | | |
| 154 | 22455-18-1 | Platinum,dichloro[1,1'-[1,2-ethanediylbis(thio)]bis[benzene]-S,S']-, (SP-4-2)- (9CI) | C14H16Cl2PtS2 | 514.39 | | |
| 155 | 22455-51-2 | 2-CHLORO-N-(4,5,6,7-TETRAHYDRO-BENZOTHIAZOL-2-YL)-ACETAMIDE | C9H11ClN2OS | 230.71 | | |
| 156 | 22455-69-2 | 2-Imidazolidinone, 1-(2-hydroxyethyl)-3-methyl- | C6H12N2O2 | 144.17 | | |
| 157 | 22455-92-1 | 2,4(1H,3H)-Pyrimidinedione, 1-(4-methylphenyl)- | C11H10N2O2 | 202.21 | | |
| 158 | 22455-93-2 | 1-(4-Methoxyphenyl)pyriMidine-2,4(1H,3H)-dione | C11H10N2O3 | 218.21 | 230.5-231.5℃ | |
| 159 | 224558-17-2 | 224558-17-2 | C15H22Br2O2 | 394.14198 | | |
| 160 | 22456-35-5 | 1-Piperidineethanol, a-[(2,4-dichlorophenoxy)methyl]-,hydrochloride (1:1) | C14H20Cl3NO2 | 340.6731 | | |
| 161 | 22456-39-9 | 1-(4-CHLORO-3-METHYLPHENOXY)-3-PIPERIDIN-1-YLPROPAN-2-OL HYDROCHLORIDE | C15H23Cl2NO2 | 320.25 | | |
| 162 | 22456-93-5 | 4H-1-Benzopyran-4-one,2-ethyl-2,3-dihydro- | C11H12O2 | 176.21178 | | |
| 163 | 22456-95-7 | chloro-methyl-propyl-thioxo-phosphorane | C4H10ClPS | 156.61 | | |
| 164 | 224560-54-7 | 2H-Pyran-4-carboxylicacid,4-aminotetrahydro-2-methyl-,(2R,4S)-rel-(9CI) | C7H13NO3 | 159.18302 | | |
| 165 | 224560-71-8 | Benzeneacetic acid, 2-bromo-4-ethyl-, methyl ester | C11H13BrO2 | 257.12 | | |
| 166 | 224560-74-1 | 2H-Pyran-4-carbonitrile,4-aminotetrahydro-2-methyl-(9CI) | C7H12N2O | 140.18 | | |
| 167 | 224561-28-8 | 2-Pyrrolidinone, 1-(phenylmethyl)-3-(2-propen-1-yl)- | C14H17NO | 215.29 | | |
| 168 | 224561-50-6 | 2-Pyrrolidinone,4-(2-propenyl)-(9CI) | C7H11NO | 125.17 | | |
| 169 | 224563-83-1 | 4(1H)-Pyridinone, 1-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]propyl]-3-hydroxy-2-methyl- | C23H33NO3 | 371.51 | | |
| 170 | 224563-84-2 | 4(1H)-Pyridinone, 1-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]propyl]-3-hydroxy-2-methyl-, methanesulfonate (1:1) | C24H37NO6S | 467.62 | | |
| 171 | 224566-03-4 | 3-PHENYL-5-ISOXAZOLYL 4-CHLOROBENZENECARBOXYLATE | C16H10ClNO3 | 299.71 | | |
| 172 | 224566-27-2 | 1-(9-ANTHRACENYLMETHYL)-PIPERIDINE-4-CARBOXYLIC ACID | C21H21NO2 | | | |
| 173 | 224566-30-7 | Ergosta-8,24(28)-dien-3-ol, 4-methyl-, (3β,4α,5α,14β)- | C29H48O | 412.69 | | |
| 174 | 224567-64-0 | 6H-2-Benzopyran-6-one,5-chloro-3-[(1E,5S)-3,5-dimethyl-1,3-heptadien-1-yl]-7,8-dihydro-7-hydroxy-7-methyl-8-(2-oxopropyl)-,(7R,8R)- | C22H27ClO4 | 390.90038 | | |
| 175 | 224568-13-2 | Linolenic-1-13C Acid | C1713CH30O2 | 279.42 | | |
| 176 | 224568-17-6 | 3-(3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-yl)-propionic acid | C7H10N2O3 | 170.17 | | |
| 177 | 224568-66-5 | Coumarin 120 | C15H19NO3 | 261.32 | | |
| 178 | 2245691-60-3 | Benzoic acid, 4-[[[1,2-dihydro-8-(methylamino)-2-oxo-3-quinolinyl]carbonyl]amino]- | C18H15N3O4 | 337.33 | | |
| 179 | 2245693-15-4 | TP0480066 | C18H14FN3O5 | 371.32 | | |
| 180 | 2245694-97-5 | 2H-Isoindole-2-acetamide, N-[2-(2-chlorobenzoyl)-4-nitrophenyl]-1,3-dihydro-1,3-dioxo- | C23H14ClN3O6 | 463.83 | | |
| 181 | 2245697-83-8 | (S,R,S)-AHPC-C3-NH2 (VH032-C3-NH2) | C27H40ClN5O4S | 566.16 | | |
| 182 | 2245697-84-9 | N-(2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride | C23H31ClN4O9 | 542.97 | | |
| 183 | 2245697-85-0 | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride | C25H35ClN4O10 | 587.02 | | |
| 184 | 2245697-85-0 | Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride | C25H35ClN4O10 | 587.02 | | |
| 185 | 2245697-86-1 | Thalidomide-O-amido-C4-NH2 hydrochloride | C19H23ClN4O6 | 438.87 | | |
| 186 | 2245697-87-2 | Thalidomide-PEG2-C2-NH2 hydrochloride | C19H25ClN4O6 | 440.88 | | |
| 187 | 2245697-88-3 | Thalidomide-O-C6-NH2 hydrochloride | C19H24ClN3O5 | 409.87 | | |
| 188 | 2245697-92-9 | Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- | C19H17NO2 | 291.34 | | |
| 189 | 2245698-48-8 | DM4-SPDP | C45H61ClN4O14S2 | 981.57 | | |
| 190 | 22457-12-1 | Morpholine,4-[(bromomethyl)sulfonyl]- | C5H10BrNO3S | 244.1068 | | |
| 191 | 22457-16-5 | Benzenemethanesulfonamide,N-(1,1-dimethylethyl)-a-nitro- | C11H16N2O4S | 272.32074 | | |
| 192 | 22457-23-4 | Stemone | C8H17NO | 143.23 | | |
| 193 | 22457-25-6 | 3,7-dimethyloct-6-enal oxime | C10H19NO | 169.26396 | | |
| 194 | 22457-26-7 | (NE)-N-(3,7-dimethyloctylidene)hydroxylamine | C10H21NO | 171.28 | | |
| 195 | 22457-33-6 | Nonanoic acid, 9-chloro-, methyl ester | C10H19ClO2 | 206.71 | | |
| 196 | 22457-53-0 | Phosphorodiamidic acid, methyl ester | CH7N2O2P | 110.05 | | |
| 197 | 22457-55-2 | 3-PHOSPHO-D-GLYCERIC ACID BARIUM SALT | C3H8BO7P | 197.876181 | | |
| 198 | 22457-81-4 | (4-hydroxycyclohexyl)urea | C7H14N2O2 | 158.2 | | |
| 199 | 22457-89-2 | S-benzoylthiamine O-monophosphate | C19H23N4O6PS | 466.45 | 165 C | |
| 200 | 2245700-42-7 | ATTO Rho6G-NHS | C35H39N4O6 | 611.71 | | |
| 201 | 2245700-60-9 | Carmichasine B | C31H41NO7 | 539.66 | | |
| 202 | 2245705-12-6 | OseltamivirImpurity136 | C16H27NO5 | 313.39 | | |
| 203 | 2245708-24-9 | 2,5-bis((hydrazinyloxy)carbonyl)benzene-1,4-diol | C8H10N4O4 | 226.19 | | |
| 204 | 2245708-25-0 | 1,4-Benzenedicarboxylic acid, 2,3-dihydroxy-, 1,4-diethyl ester | C12H14O6 | 254.24 | | |
| 205 | 2245708-68-1 | 2-Amino-6-(propylamino)-5,6-dihydrobenzo[d]thiazol-7(4H)-one hydrochloride | C10H16ClN3OS | 261.77154 | | |
| 206 | 2245709-19-5 | 4-nitroso-1lambda6-thiomorpholine-1,1-dione | C4H8N2O3S | 164.18 | | |
| 207 | 224571-49-7 | 2-(2-chloro-1,1-dimethylethyl)phenyl ethyl ether | C12H17ClO | 212.71578 | | |
| 208 | 2245711-21-9 | 1-Propanaminium, 3-carboxy-2-(4-carboxy-1-oxobutoxy)-N,N-dimethyl-N-(methyl-d3)-, (2R)-, perchlorate (1:1) | C12H22ClNO10 | 375.76 | | |
| 209 | 2245711-23-1 | 1-Propanaminium, 3-carboxy-2-(3-hydroxy-3-methyl-1-oxobutoxy)-N,N-dimethyl-N-(methyl-d3)-, (2R)-, perchlorate (1:1) | C12H24ClNO9 | 361.77 | | |
| 210 | 2245711-25-3 | 1-Propanaminium, 3-carboxy-N,N,N-tri(methyl-d3)-2-[(1-oxododecyl)oxy]-, chloride (1:1), (2R)- | C19H38ClNO4 | 379.97 | | |
| 211 | 2245711-27-5 | Stearoyl-L-carnitine-d3 chloride (L-Stearoylcarnitine-d3) | C25H47D3NO4 • Cl | 467.13972 | | |
| 212 | 2245711-29-7 | L-CARNITINE(MONO):CLO4, O-3-DL-HYDROXYPALMITOYL (N-METHYL-D3, 98%) | C23H46ClNO9 | 516.07 | | |
| 213 | 2245713-18-0 | 1-Propanaminium, 3-carboxy-N,N,N-tri(methyl-d3)-2-[(1-oxotetradecyl)oxy]-, inner salt, (2R)- | C21H41NO4 | 371.56 | | |
| 214 | 2245716-09-8 | 1H-Pyrazole, 5-[[(4-methoxyphenyl)methoxy]methyl]-1,3-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- | C20H29BN2O4 | 372.27 | | |
| 215 | 2245716-32-7 | 1H-Pyrazole-3-methanol, 5-[[(4-hydroxy-2-naphthalenyl)thio]methyl]-1-methyl- | C16H16N2O2S | 300.38 | | |
| 216 | 2245721-80-4 | Famciclovir-d2 | C14H17D2N5O4 | 323.34 | | |
| 217 | 2245725-04-4 | Research Grade Tebotelimab (DHD30407) | | | | |
| 218 | 2245726-35-4 | 5,8,11,14,17-Eicosapentaenoic acid, 2-hydroxy-3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]oxy]propyl ester, (5Z,8Z,11Z,14Z,17Z)- | C41H66O5 | 638.96 | | |
| 219 | 2245726-36-5 | 5,8,11,14,17-Eicosapentaenoic acid, 2-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]oxy]-3-[[(9Z,12Z,15Z)-1-oxo-9,12,15-octadecatrien-1-yl]oxy]propyl ester, (5Z,8Z,11Z,14Z,17Z)- | C59H94O6 | 899.37 | | |
| 220 | 224573-17-5 | L-Tryptophanamide, 5-oxo-L-prolyl-L-leucyl-L-asparaginyl-L-phenylalanyl-L-threonyl-L-prolyl-L-seryl- | C47H63N11O12 | 974.07 | | |
| 221 | 224575-20-6 | Pyridine, 2-(aminooxy)-6-fluoro- (9CI) | C5H5FN2O | 128.1044032 | | |
| 222 | 224575-61-5 | Phosphonic acid, P-[1-[(1,1-dimethylethyl)(phenylmethoxy)amino]-2,2-dimethylpropyl]-, diethyl ester | C20H36NO4P | 385.48 | | |
| 223 | 224575-62-6 | Phosphonic acid, P-[1-[(1,1-dimethylethyl)(1-phenylethoxy)amino]-2,2-dimethylpropyl]-, diethyl ester | C21H38NO4P | 399.5 | | |
| 224 | 224576-53-8 | 1H-Azepine-1-carboxylicacid,4,5-dihydro-,methylester(9CI) | C8H11NO2 | | | |
| 225 | 2245767-16-0 | Benzamide, N-[2-fluoro-5-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-methoxy-5-propyl- | C23H20FN3O4 | 421.42 | | |
| 226 | 2245772-36-3 | 2-(2-Bromophenyl)pyridine-κN]chloro[(1,2,5,6-η)-1,5-cyclooctadiene]iridium | | | | |
| 227 | 2245785-75-3 | Prucalopride Impurity 31 | C30H46ClN3O13 | 692.16 | | |
| 228 | 224579-74-2 | MYOSIN LIGHT CHAIN KINASE INHIBITOR PEPTIDE 18 | C60H105N23O11 | 1324.62 | | |
| 229 | 2245794-64-1 | N-Acetylmuramic acid-azide | C11H18N4O8 | 334.28 | | |
| 230 | 2245794-65-2 | (2R)-2-(((3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-3-(pent-4-ynamido)tetrahydro-2H-pyran-4-yl)oxy)propanoic acid | C14H21NO8 | 331.32 | | Soluble to 100 mM in water |
| 231 | 22458-07-7 | Benzamide,2-[(4-chloro-1-oxobutyl)amino]- | C11H13ClN2O2 | 240.68612 | | |
| 232 | 22458-10-2 | 1H,2H,3H,3aH,4H,9H-pyrrolo[2,1-b]quinazolin-9-one | C11H12N2O | 188.23 | 184 °C | |
| 233 | 22458-23-7 | 2,5-Dihydroxy-1-methyl-5-phenylpyrimidine-4,6(1H,5H)-dione | C11H10N2O4 | 234.21 | | |
| 234 | 22458-49-7 | 3-(2,4-DIMETHYL-PHENYL)-2-MERCAPTO-3H-QUINAZOLIN-4-ONE | C16H14N2OS | 282.36 | | |
| 235 | 22458-63-5 | 1-Isocyanato-2-(3-isocyanatopropyl)cyclohexane | | | | |
| 236 | 224580-59-0 | 2H-Pyran-2-one,tetrahydro-4-hydroxy-5-methyl-6-(1-methylethyl)-,(4S,5S,6R)-(9CI) | C9H16O3 | | | |
| 237 | 2245800-85-3 | Glycine, N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-N-[2-[2-[[(4-methoxyphenyl)methyl]thio]-4-oxo-1(4H)-pyrimidinyl]acetyl]- | C33H32N4O7S | 628.69 | | |
| 238 | 2245801-13-0 | L-Phenylalanine, N,3-bis[(1,1-dimethylethoxy)carbonyl]- | C19H27NO6 | 365.42 | | |
| 239 | 2245809-15-6 | 4-Oxooctanoyl-CoA | | | | |
| 240 | 2245809-16-7 | 5-Oxohexanoyl-CoA | | | | |
| 241 | 2245809-17-8 | 5-Oxooctanoyl-CoA | | | | |
| 242 | 224581-87-7 | Indeno[2,1-b]indole, 5,6-dihydro-2,5-dimethyl- | C17H15N | 233.31 | | |
| 243 | 224581-93-5 | 1,3-Cyclopentadiene,2-(1,1-dimethylethyl)-5-(1-methylethyl)-(9CI) | C12H20 | 164.2872 | | |
| 244 | 2245810-58-4 | tert-Butyl ((1S,2R)-2-((S)-2-amino-1-(1-benzylpiperidin-4-yl)-1-(3-fluorophenyl)ethyl)cyclopentyl)carbamate | C30H42FN3O2 | 495.67 | | |
| 245 | 2245811-12-3 | Pitavastatin 3-Oxo SodiuM | C25H22FNO4 | 419.44 | | |
| 246 | 2245814-60-0 | tetraethyl 2,2'-((p-tolylazanediyl)bis(bicyclo[2.2.1]hepta-1,3,5-triene-7,7-diyl))dimalonate | C35H41NO8 | 603.71 | | |
| 247 | 2245819-88-7 | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propane-1-sulfonamide | C16H26BNO5S | 355.26 | | |
| 248 | 2245820-70-4 | Methanesulfonamide, N-[3-[2-amino-5-[4-(1-piperazinyl)phenyl]-3-pyridinyl]-5-methoxyphenyl]- | C23H27N5O3S | 453.56 | | |
| 249 | 2245823-65-6 | (6-(chloromethyl)pyridin-2-yl)methanamine | C7H10Cl2N2 | 193.07 | | |
| 250 | 2245823-67-8 | tert-butyl (S)-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)carbamate | C16H24N2O4 | 308.37276 | | |
| 251 | 2245824-02-4 | Carbamic acid, N-[trans-4-[(4-bromophenyl)amino]cyclohexyl]-, 1,1-dimethylethyl ester | C17H25BrN2O2 | 369.3 | | |
| 252 | 224583-35-1 | 6-N-Biotinylaminohexyl Hydrogenphosphonate | C16H30N3O5PS | 407.47 | | |
| 253 | 224583-37-3 | 6-N-Biotinylaminohexyl Isopropyl Hydrogenphosphonate | C19H36N3O5PS | 449.55 | | |
| 254 | 224584-16-1 | Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-iodo- | C6H7IO2 | 238.02 | | |
| 255 | 224584-18-3 | 3-(Trifluoromethyl)bicyclo[1.1.1]pentane-1-carboxylicacid | C7H7F3O2 | 180.1244896 | | |
| 256 | 2245840-94-0 | Methyl 2-(trans-4-(aminomethyl)cyclohexyl)acetate hydrochloride | C10H20ClNO2 | 221.73 | | |
| 257 | 2245842-16-2 | 2'-Deoxy-5'-O-(4,4'-dimethoxytrityl)-2'-fluoro inosine 3'-CED phosphoramidite | C40H46FN6O7P | 772.82 | | |
| 258 | 2245848-05-7 | Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1′(2′H)-naphthalen]-8(9H)-one, 6′-chloro-3′,4′,12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1′S,11R,12S,14E,16R,16aR,18aR)- | C42H57ClN4O5S | 765.44 | | |
| 259 | 224586-49-6 | 3,5-DIMETHOXY-4-(1-METHYLPROPOXY)BENZALDEHYDE | C13H18O4 | 238.27962 | | |
| 260 | 2245862-72-8 | (R)-4-Oxo-octahydro-pyrido[1,2-a]pyrazine-2-carboxylic acid benzyl ester | C16H20N2O3 | 288.34 | | |
| 261 | 2245880-46-8 | PF-07338233 | C14H23N3O8S | 393.41 | | |
| 262 | 2245886-82-0 | 3-Pyridinemethanol, 2-[1-(1-methylethyl)-1H-pyrazol-5-yl]-, hydrochloride (1:1) | C12H16ClN3O | 253.73 | | |
| 263 | 2245887-38-9 | DI-591(DI591) | C31H47N5O4S | 585.81 | | |
| 264 | 2245892-85-5 | 4-methyl-3-((2-methyl-6-(pyridin-3-yl)-2H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-N-(3-(trifluoromethyl)phenyl)benzamide | C26H20F3N7O | 503.48 | | |
| 265 | 2245893-16-5 | Boric acid (H3BO3), dibutyl ethenyl ester | C10H21BO3 | 200.09 | | |
| 266 | 2245893-17-6 | Boric acid (H3BO3), dibutyl 2-propyn-1-yl ester | C11H21BO3 | 212.1 | | |
| 267 | 2245895-44-5 | 2245895-44-5 | C28H20O10 | 516.46 | | |
| 268 | 2245896-67-5 | N,N'''-[[5,5-Bis[[4-(1,1-dimethylethyl)phenyl]methyl]dihydro-2,4,6-trioxo-1,3(2H,4H)-pyrimidinediyl]di-4,1-butanediyl]bis[guanidine | | | | |
| 269 | 22459-01-4 | Benzoicacid,2-hydroxy-,cyanomethylester | C9H7NO3 | 177.15678 | | |
| 270 | 22459-10-5 | 1,7-Octadien-3-ol, 2-methyl-6-methylene- | C10H16O | 152.23 | | |
| 271 | 22459-17-2 | Morpholine, 4-(bicyclo[2.2.1]hept-2-ylmethyl)- (9CI) | C12H21NO | 195.30124 | | |
| 272 | 22459-57-0 | 1,2,4,5-Tetrazine,1,2,5,6-tetrahydro-1,3,5-triphenyl- | C20H18N4 | 314.38372 | | |
| 273 | 22459-72-9 | 4-Chloro-5-nitro-o-anisidine, 2-Amino-5-chloro-4-nitroanisole | C7H7ClN2O3 | 202.6 | 132 °C | |
| 274 | 22459-75-2 | Benzamide, 5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-4-nitro- | C14H20ClN3O4 | 329.78 | | |
| 275 | 22459-81-0 | 4-Bromo-3-Chloroacetanilide | C8H7BrClNO | 248.5 | 125 °C | |
| 276 | 22459-83-2 | N-(3-bromo-4-chlorophenyl)acetamide(WS205137) | C8H7BrClNO | 248.5 | | |
| 277 | 2245927-45-9 | 5H-Benzo[b]carbazole, 2-chloro- | C16H10ClN | 251.71 | | |
| 278 | 2245938-86-5 | 1H-Pyrazole-3-carboxylic acid, 5-(chloromethyl)-1-methyl-, methyl ester | C7H9ClN2O2 | 188.61 | | |
| 279 | 2245942-72-5 | SS-208 | C13H11Cl2N3O4 | 344.15 | | |
| 280 | 2245946-45-4 | Janelia Fluor 549, free acid | C29H23F3N2O7 | 568.51 | | |
| 281 | 2245949-62-4 | SC-919 | C19H16Cl2N2O4 | 407.25 | | |
| 282 | 2245949-67-9 | methyl 5'-chloro-2',4-dioxo-1',2'-dihydrospiro[cyclohexane-1,3'-pyrrolo[3,2-b]pyridine]-3-carboxylate | C14H13ClN2O4 | 308.72 | | |
| 283 | 2245953-10-8 | NA | | | | |
| 284 | 2245966-28-1 | Daxdilimab | | | | |
| 285 | 2245967-07-9 | 2(1H)-Pyridinone, 4-bromo-5-(2,2,3,3,3-pentafluoropropoxy)- | C8H5BrF5NO2 | 322.03 | | |
| 286 | 2245970-67-4 | 7-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid benzyl ester | C23H28BNO4 | 393.29 | | |